No evidence for hypogammaglobulinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with ravulizumab

• Ferras Alashkar,

  Roles Formal analysis, Investigation, Methodology, Project administration, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Department of Hematology, West German Cancer Center, University Hospital Essen, Essen, Germany

  http://orcid.org/0000-0001-7530-8892

  ⨯
• Scott Rottinghaus,

  Roles Writing – review & editing

  Affiliation Alexion Pharmaceuticals, Inc, Boston, MA, United States of America

  ⨯
• Colin Vance,

  Roles Validation

  Affiliation Rheinisch-Westfälisches Institut für Wirtschaftsforschung, Essen, Germany

  ⨯
• Dörte Herich-Terhürne,

  Roles Formal analysis

  Affiliation Department of Hematology, West German Cancer Center, University Hospital Essen, Essen, Germany

  ⨯
• Ulrich Dührsen,

  Roles Validation

  Affiliation Department of Hematology, West German Cancer Center, University Hospital Essen, Essen, Germany

  ⨯
• Roland Assert,

  Roles Writing – review & editing

  Affiliation Department of Clinical Chemistry, University Hospital Essen, Essen, Germany

  ⨯
• Alexander Röth

  Roles Formal analysis, Investigation, Project administration, Supervision, Validation

  * E-mail: alexander.roeth@uk-essen.de

  Affiliation Department of Hematology, West German Cancer Center, University Hospital Essen, Essen, Germany

  ⨯